Skip to main content
. 2021 Dec 28;12:788107. doi: 10.3389/fendo.2021.788107

Table 4.

Clinical and laboratory parameters according to the use of medications for T2DM.

Without medicationsN = 15 With medications N = 79 P
Age (years) 56.0 ± 9.9 58.9 ± 7.7 0.21
Duration of T2D (years) 2.02 ± 3.2 7.7 ± 5.4 0.003
Hemoglobin A1c (%) 6.60 ± 0.68 7.95 ± 1.74 0.004
Osteocalcin (ng/ml) 6.64 ± 2.0 4.40 ± 2.90 0.01
CTx (ng/ml) 0.39 ± 0.15 0.21 ± 0.13 0.0001
Sclerostin (ng/ml) 0.66 ± 0.18 0.79 ± 0.23 0.07
PTH (pg/ml) 61.77 ± 27.72 47.77 ± 26.02 0.12

T2D, type 2 diabetes mellitus; CTx, C-terminal telopeptide of collagen I; PTH, parathyroid hormone. Bolded p-values are significant.